Generic and biosimilar medicines: quid?

Generic and biosimilar medicines: quid?

Once intellectual property protection, data and marketing exclusivity of reference medicines have expired, generic medicines and biosimilar medicines can enter the off-patent market. This market entry is conditional on the approval of marketing authorization, pricing and reimbursement. Given that th...

Full description

Bibliographic Details
Main Author: Steven Simoens
Format: Article
Language:English
Published: SEEd Medical Publishers 2012-12-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:
generic medicine
biosimilars
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/448
id doaj-6f5b42e5dde14ac3a97b64633378a511
record_format Article
spelling doaj-6f5b42e5dde14ac3a97b64633378a5112020-11-25T02:56:06ZengSEEd Medical PublishersFarmeconomia: Health Economics and Therapeutic Pathways2240-256X2012-12-01133S3410.7175/fe.v13i3S.448441Generic and biosimilar medicines: quid?Steven Simoens0Department of Pharmaceutical and Pharmacological Sciences, KU LeuvenOnce intellectual property protection, data and marketing exclusivity of reference medicines have expired, generic medicines and biosimilar medicines can enter the off-patent market. This market entry is conditional on the approval of marketing authorization, pricing and reimbursement. Given that there tends to be confusion surrounding generic and biosimilar medicines, this Editorial introduces basic concepts related to generic and biosimilar medicines and presents the different studies and articles included in this supplement dedicated to generic and biosimilar medicines.https://journals.seedmedicalpublishers.com/index.php/FE/article/view/448generic medicinebiosimilars
collection DOAJ
language English
format Article
sources DOAJ
author Steven Simoens
spellingShingle Steven Simoens
Generic and biosimilar medicines: quid?
Farmeconomia: Health Economics and Therapeutic Pathways
generic medicine
biosimilars
author_facet Steven Simoens
author_sort Steven Simoens
title Generic and biosimilar medicines: quid?
title_short Generic and biosimilar medicines: quid?
title_full Generic and biosimilar medicines: quid?
title_fullStr Generic and biosimilar medicines: quid?
title_full_unstemmed Generic and biosimilar medicines: quid?
title_sort generic and biosimilar medicines: quid?
publisher SEEd Medical Publishers
series Farmeconomia: Health Economics and Therapeutic Pathways
issn 2240-256X
publishDate 2012-12-01
description Once intellectual property protection, data and marketing exclusivity of reference medicines have expired, generic medicines and biosimilar medicines can enter the off-patent market. This market entry is conditional on the approval of marketing authorization, pricing and reimbursement. Given that there tends to be confusion surrounding generic and biosimilar medicines, this Editorial introduces basic concepts related to generic and biosimilar medicines and presents the different studies and articles included in this supplement dedicated to generic and biosimilar medicines.
topic generic medicine
biosimilars
url https://journals.seedmedicalpublishers.com/index.php/FE/article/view/448
work_keys_str_mv AT stevensimoens genericandbiosimilarmedicinesquid
_version_ 1724714212157030400

Similar Items